Detalles de la búsqueda
1.
Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Stem Cells
; 26(12): 3059-67, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19096043
2.
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
Haematologica
; 94(8): 1124-34, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19546437
3.
High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
Clin Cancer Res
; 11(18): 6520-7, 2005 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16166428
4.
Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch Working Party on Flow Cytometry in MDS.
Leuk Res
; 36(4): 422-30, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21982641
5.
Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival.
Leuk Lymphoma
; 49(1): 134-48, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17926185
6.
Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.
Blood
; 111(3): 1067-77, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17971483
7.
Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
Br J Haematol
; 134(3): 283-93, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16848771
Resultados
1 -
7
de 7
1
Próxima >
>>